Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
1279results about How to "Good for weight loss" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Apparatus and method for intragastric balloon with in situ adjustment means
ActiveUS20080172079A1Good for weight lossEncourage early satietySurgeryDilatorsSurgeryInstrumentation
An intragastric balloon and method of adding and / or removing fluid therefrom are disclosed. The intragastric balloon includes a shell, a grasping tab, and a self-sealing portion. A gastroscopic instrument which includes a grasping tool is inserted into the stomach of a patient and used to grasp the grasping tab located on the surface of the shell. Using the grasping tool, the intragastric balloon is securely fastened to the gastroscopic instrument. A filling instrument, such as a needle, is advanced through the self-sealing portion of the shell for the filling or deflating of the intragastric balloon. After inflation or deflation is complete, the filling instrument is then withdrawn from the balloon and the gastroscopic instrument withdrawn from the stomach.
Owner:APOLLO ENDOSURGERY INC
Systems and methods for treating obesity
ActiveUS7753870B2Reduce food intakeGood for weight lossIntravenous devicesTubular organ implantsPylorusGastric emptying
Methods and devices for simulating a gastric bypass and reducing the volume of the stomach involve placing a tubular liner along the lesser curve of the stomach cavity. Also, methods and devices for slowing gastric emptying involve placing valves within the stomach cavity near the gastro-intestinal junction and / or the pylorus. These methods and devices may prevent a patient from drinking and eating large volumes at one time and from eating slowly all day.
Owner:ETHICON ENDO SURGERY INC
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
ActiveUS20120058094A1Good for weight lossReduce the populationBiocideMetabolism disorderBiotechnologyDisease
The present invention relates to characterizing changes in mammalian intestinal microbiota associated with associated with high-fat and low-fat diets and with diets containing hydroxypropylmethylcellulose (HPMC) and related methods for diagnosing, preventing and treating obesity and related conditions such as metabolic syndrome and diabetes mellitus. Therapeutic methods of the invention involve the use of probiotics, and / or prebiotics, and / or narrow spectrum antibiotics / anti-bacterial agents that are capable of restoring healthy mammalian bacterial intestinal microbiota.
Owner:NEW YORK UNIV
Remote deflation of intragastric balloon
An intragastric balloon system for facilitating weight loss in a human or animal patient generally includes a flexible shell suitable for placement in a digestive track of a patient and capable of being inflated with a fluid. The system further includes a valve mechanism coupled to the shell, an actuator for opening the valve mechanism to effect release of fluid from the shell, and a remote control device capable of sending a signal from outside the patient to the actuator in order to effectuate deflation of the shell in vivo and without surgical intervention.
Owner:APOLLO ENDOSURGERY INC
New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin
InactiveUS20100317729A1Enhanced treatment optionGood for weight lossBiocideNervous disorderCannabinoidPharmaceutical formulation
The present invention relates to a novel pharmaceutical formulation comprising a ratioed mix of: (i) one or more compounds that acts as an inverse agonist of the CB1 and / or CB2 receptor; and (ii) one or more compounds that acts as a neutral antagonist of the CB1 and / or CB2 receptor. Preferably both the inverse agonist of the CB1 and / or CB2 receptor and the neutral antagonist of the CB1 and / or CB2 receptor are cannabinoids. Preferably the cannabinoids are tetrahydrocannabidivarin (THCV) and cannabidiol (CBD).
Owner:GW PHARMA LTD
Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
An improved ultra-high fiber supplement that promotes satiety, caloric reduction, and weight loss. The supplement comprises guar, oat, psyllium, locust bean gum, pectin, green tea, multi-anthocyanadins, pyridoxine, and folic acid. The supplement can exist as a liquid, semi-solid, or solid comestible. It improves cardiovascular health and reduces cardiovascular inflammation and the risk of heart disease. The addition of antioxidants, including green tea, improves weight loss, and general and cardiovascular health. Also it reduces serum lipoprotein oxidation and risk of free-radical related diseases. Consumption of the supplement aids in reducing absorption and assimilation of ingested toxins. A method of providing an ultra-high fiber comestible that is highly palatable and can be used to supplement nutrition and to manage and prevent diet-related diseases is disclosed. Further embodiments increase fiber and other nutrients in the diet and helps manage and prevent all diet-related diseases.
Owner:SMALL GIANT
Apparatus for treating obesity by extracting food
ActiveUS20050277900A1Good for weight lossEasy to implementMedical devicesCatheterSide effectAbdominal wall
The present invention is directed to an apparatus and method for treating obesity. A tube is positioned that passes through a patient's abdominal wall into the upper digestive system of the patient. The patient is allowed to carry out his / her everyday affairs including ingesting food. After the patient has ingested food, the food is extracted by pumping it out of the upper digestive system through the tube. The present invention is less invasive than current surgical procedures for reducing weight and allows patients to live a normal and active lifestyle without experiencing adverse side effects.
Owner:ASPIRE BARIATRICS
Acylated glucagon analogues
InactiveUS20120178670A1Avoid weight gainGood for weight lossPeptide/protein ingredientsAntipyreticDiabetes mellitusWeight gain prevention
The invention provides materials and methods for promoting weight loss or preventing weight gain, and in the treatment of diabetes and associated metabolic disorders. In particular, the invention provides novel acylated glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
Owner:ZEALAND PHARM AS
Fruit and vegetable probiotic tablet and preparation method thereof
ActiveCN104489646AHigh survival rate of live bacteriaImprove stabilityNatural extract food ingredientsFood ingredient functionsCelluloseDrug biological activity
The present invention discloses a fruit and vegetable probiotic tablet and a preparation method thereof. The fruit and vegetable probiotic tablet uses probiotic powders such as lactobacillus plantarum powder as the main raw material, and the preparation method scientifically mixes modified dietary fibers, fruit and vegetable powder, oligosaccharides, plant extracts, protein powder, tea leaf extracts and traditional Chinese medicine extracts and etc., thus improves the content of soluble celluloses which are of real significance for probiotic flora, enhances the physiological activity of celluloses, thereby increases the species of intestinal probiotic flora as well as significantly enhances the colonization ability and time of endogenous and exogenous probiotics in the human intestinal tracts, effectively inhibits the growth and reproduction of harmful intestinal bacteria, especially gram-negative bacteria, and fully regulates the composition of the intestinal probiotic flora. The prepared fruit and vegetable probiotic tablet has a high biological activity, a long human intestinal colonization time, and a significant weight loss effect, and is suitable for a wide range of people.
Owner:南京旭优食品技术有限公司
Compositions and methods for treating obesity and related disorders
InactiveUS20080255093A1Reduces unwanted side effectGood for weight lossBiocideNervous disorderSYMPATHOMIMETIC AGENTSSerotonin receptor agonist
The present invention is drawn to combinations of pharmaceutical agents having similar chemical and / or pharmacological properties, wherein the combinations maximize the therapeutic effect of the drug while minimizing their adverse effects. The methods and compositions of the invention are particularly useful in the treatment of obesity and related conditions which involves treating a subject with a sympathomimetic agent (e.g., phentermine or a phentermine-like drug) or bupropion in combination with an anti-epileptic agent (e.g., topiramate, zonisamide), CB1 antagonists (e.g., rimonabant), or a 5HT2C-selective serotonin receptor agonist, (e.g., lorcaserin) for the treatment of obesity and related conditions. The invention also features kits for use in the practice of these novel therapies.
Owner:VIVUS
Pressure sensing intragastric balloon
An intragastric balloon having a built-in sensor. The sensor may be used to monitor pressure within the balloon shell, or outside of the shell in the stomach. The sensor may be used after deflation of the intragastric balloon to monitor the pressure through the intestinal tract as the balloon migrates therethrough. An apparatus for remote deflation of the balloon may be utilized to allow a physician to deflate the intragastric balloon without surgery. The pressure sensor may be provided in a valve of the intragastric balloon which separates from the balloon and migrates as a capsule through the intestinal tract to monitor conditions therein.
Owner:APOLLO ENDOSURGERY INC
Compositions and methods for producing elevated and sustained ketosis
ActiveUS9138420B2Rapid and sustained elevationImprove the level ofHydroxy compound active ingredientsMetabolism disorderSignificant elevationKetogenic diet
Beta-hydroxybutyrate mineral salts in combination with medium chain fatty acids or an ester thereof such as medium chain triglycerides were used to induce ketosis, achieving blood ketone levels of (2-7 mmol / L), with or without dietary restriction. The combination results in substantial improvements in metabolic biomarkers related to insulin resistance, diabetes, weight loss, and physical performance in a short period of time. Further, use of these supplements to achieve ketosis yields a significant elevation of blood ketones and reduction of blood glucose levels. Use of these substances does not adversely affect lipid profiles. By initiating rapid ketosis and accelerating the rate of ketoadaptation, this invention is useful for the avoidance of glucose withdrawal symptoms commonly experienced by individuals initiating a ketogenic diet, and minimizes the loss of lean body mass during dietary restriction.
Owner:UNIV OF SOUTH FLORIDA
Compositions and methods for producing elevated and sustained ketosis
ActiveUS20140350105A1Rapid and sustained elevationImprove metabolic healthBiocideHydroxy compound active ingredientsKetoneSignificant elevation
Beta-hydroxybutyrate mineral salts in combination with medium chain fatty acids or an ester thereof such as medium chain triglycerides were used to induce ketosis, achieving blood ketone levels of (2-7 mmol / L), with or without dietary restriction. The combination results in substantial improvements in metabolic biomarkers related to insulin resistance, diabetes, weight loss, and physical performance in a short period of time. Further, use of these supplements to achieve ketosis yields a significant elevation of blood ketones and reduction of blood glucose levels. Use of these substances does not adversely affect lipid profiles. By initiating rapid ketosis and accelerating the rate of ketoadaptation, this invention is useful for the avoidance of glucose withdrawal symptoms commonly experienced by individuals initiating a ketogenic diet, and minimizes the loss of lean body mass during dietary restriction.
Owner:UNIV OF SOUTH FLORIDA
Heteroaryl Substituted Piperazinyl-Pyridine Analogues
InactiveUS20080124384A1Inhibit bindingGood for weight lossBiocideOrganic active ingredientsArylDisease
Substituted biaryl piperazinyl-pyridine analogues are provided, of the Formula: wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
Owner:NEUROGEN
Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
InactiveUS20080268038A1Good for weight lossIncreased DITBiocideSalicyclic acid active ingredientsMethionine biosynthesisL-threonine
Provided are compositions and methods for increasing diet induced thermogenesis. Typically, the compositions are comprised of L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-valine and L-threonine.
Owner:ENERGY LIGHT
RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)
InactiveUS20050256068A1Improves various propertyImprove the immunityCompounds screening/testingSpecial deliveryGene expressionRNA
This invention relates to compounds, compositions, and methods useful for modulating Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of Stearoyl-CoA desaturase (SCD) gene expression and / or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of Stearoyl-CoA desaturase (SCD) genes.
Owner:SIRNA THERAPEUTICS INC
Theacrine-based supplement and method of use thereof
ActiveUS20150132280A1Significant positive effectModulate effectBiocideNervous disorderDietary supplementClinical psychology
A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue.
Owner:ORTHO NUTRA
Dietary supplement and method of using same
InactiveUS20060204599A1Good for weight lossAppetite suppressantBiocideOrganic active ingredientsDietary supplementPhysical performance
A dietary supplement is provided whereby the daily administration of materials derived from the Acacia plants is provided orally to humans for the purpose of producing or maintaining weight loss as well as improving a person's physical performance and increasing the person's lean muscle mass. The Acacia materials include these portions of the plant that are normally considered waste or inedible, such as leaves, bark, and roots. The materials can be administered in their natural form or as extracts, and can be administered in various ways including capsules and tablets. The Acacia material may also be used as a tea. For weight loss and weight control, the materials may also be administered concurrently with caloric restriction or in the absence of caloric restriction. The materials may also be administered for the purpose of increasing muscle mass concurrently with a high protein diet as well as an exercise program.
Owner:WHEAT JARED R
Compositions comprising dietary fat complexer and methods for their use
InactiveUS6890549B2Decrease in levelTotal calories lowPowder deliveryOrganic active ingredientsHigh densityBioavailability
This invention relates to fat containing consumable food products comprising α-cyclodextrin. The food products have reduced levels of bioavailable fat but have substantially the same fat, cholesterol and caloric content as a like food without α-cyclodextrin. The invention also relates to methods for reducing the bioavailability of fats in fat containing food products without reducing caloric intake as determined by bomb calorimetry and to methods for increasing high density lipoproteins in a subject and reducing or controlling weight by administering the food products of this invention.
Owner:SOHO FLORDIS INT
ACE-2 modulating compounds and methods of use thereof
InactiveUS20040082496A1Less toxicReduce appetiteBiocidePeptide/protein ingredientsStereochemistryBody weight
ACE-2 modulating compounds for the treatment of body weight disorders are disclosed. Methods of using the compounds and pharmaceutical compositions containing the compounds are also claimed.
Owner:INTEL CORP
Pressure sensing intragastric balloon
An intragastric balloon having a built-in sensor. The sensor may be used to monitor pressure within the balloon shell, or outside of the shell in the stomach. The sensor may be used after deflation of the intragastric balloon to monitor the pressure through the intestinal tract as the balloon migrates therethrough. An apparatus for remote deflation of the balloon may be utilized to allow a physician to deflate the intragastric balloon without surgery. The pressure sensor may be provided in a valve of the intragastric balloon which separates from the balloon and migrates as a capsule through the intestinal tract to monitor conditions therein.
Owner:APOLLO ENDOSURGERY INC
Glucagon analogues
ActiveUS20140080757A1Avoid weight gainGood for weight lossBacteriaPeptide/protein ingredientsProviding materialObesity
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
Owner:ZEALAND PHARM AS
Wastewater treating microbial agent and preparation method thereof
ActiveCN103374525AAdaptable and TolerableGood impact resistanceBacteriaMicroorganism based processesChemistryNitric oxide
The invention discloses a wastewater treating microbial agent and a preparation method thereof. The microbial agent contains kocuriapalustris FSDN-A, arthrobactercreatinolyticus FDN-1, flavobacteriummizutaii FDN-2, paracoccusdenitrificans DN-3 and methylobacteriumphyllosphaerae SDN-3, wherein the collection register numbers of the five strains are respectively CGMCCNo.5061, CGMCCNo.3657, CGMCCNo.3659, CGMCCNo.3658 and CGMCCNo.3660. The microbial agent can achieve removal of ammonia nitrogen, total nitrogen and CODcr in the same reactor, has a good wastewater treatment effect, and can achieve short-cut nitrification and denitrification or simultaneous nitrification and denitrification while removing COD. Kocuriapalustris FSDN-A can utilize the two nitric oxides including nitrite nitrogen and nitric nitrogen, can ensure thorough denitrification of a wastewater treatment system, is slow in appreciation in the process of competing for substrates, is favorable for reduction of sludge, and further widens the application range of the microbial agent.
Owner:CHINA PETROLEUM & CHEM CORP +1
Computer program, method, and system for monitoring nutrition content of consumables and for facilitating menu planning
InactiveUS20030165799A1Good choiceTotal calories lowData processing applicationsSurgeryDiseaseNutrition
A computer program, method, and system for dynamically and interactively providing nutrition content information for consumables such that a user may monitor, tailor, plan, and review their intake thereof in light of a health-related interest or concern, such as, for example, weight-loss, food allergies, or diabetes or other nutrition affected illnesses or disabilities. Consumables are categorized and displayed in lists associated with an appropriate color to draw attention to relative nutrition content and to facilitate quicker and easier evaluation of a consumable of interest. Summaries are provided of a user's actual intake in light of a pre-established target intake for a particular day. Detailed reports may be generated showing consumption over a user-specifiable time period.
Owner:DYNAMIC NUTRITION SOLUTIONS LLC
Weight-losing fruit and vegetable powder
InactiveCN104286756AReduce intakeObvious weight loss effectVitamin food ingredientsAcidic food ingredientsAdditive ingredientTea leaf extract
The invention discloses weight-losing fruit and vegetable powder which has the characteristics that natural plants with weight-losing effects are taken as raw materials; effective ingredients in the raw materials are retained to the maximum extent by low-temperature extraction and biological enzymolysis technologies; weight-losing factors with relatively good weight-losing effects, such as dietary fibers, plant extracts, tea leaf extract, spice extract, Chinese herbal medicine extracts, probiotic powder, probiotic factors and bamboo charcoal powder, are scientifically compounded on the basis of existing nutritional fruit and vegetable powder; meanwhile, nutritional ingredients with weight-losing effects, such as protein powder, malt extract and malt flour are also compounded, and nutrients such as compound amino acids, vitamins and minerals are added; mainly proceeding from the aspects of satisfying the satiety feel, regulating gastrointestinal florae, protecting the health by traditional Chinese medicines, sucking and removing fat and the like, the digestion and absorption self-regulation capability of a human body is improved, the uptake and secondary synthetic routes of human fat are reduced, the normal nutrient uptake and metabolic level of the human body cannot be influenced, and a good cycle of health protection and weight reduction is realized.
Owner:天津天绿健科技有限公司
Dephosphorization and denitrification, mud decrement and phosphorus recovery integrated sewage treatment device and method thereof
InactiveCN101544453AImprove system synchronous denitrification and dephosphorization capacityReduce pool capacityTreatment with aerobic and anaerobic processesMultistage water/sewage treatmentContinuous flowChemistry
Owner:CHONGQING UNIV
Selenium-enriched suaeda salsa nutritional health-care fine dried noodles and production technology thereof
PendingCN106578918AReddish colorEasy to shapeYeast food ingredientsFood ingredient as taste affecting agentAdditive ingredientFried noodles
The invention discloses nutritional health-care fine dried noodles which are developed with suaeda salsa, stigma maydis and Chinese herbal medicines such as the root of kudzu vine, gynostemma pentaphyllum, cortex phellodendri, dandelions, cornus officinalis, radix rehmanniae preparata, herba portulacae, herba houttuyniae, licorice root and stevia rebaudiana as raw materials and have the effects of reducing blood lipid and blood pressure, improving organism immunity, beautifying the face and clearing away toxins, resisting fatigue and the like. The fine dried noodles contain rich functional activated substances such as suaeda salsa and amino acid, polypeptides, water-soluble dietary fibers, ferulic acid, active polysaccharides, saponin and flavone in the Chinese herbal medicines. The fine fried noodles have the advantages that compatibility of suaeda salsa and the Chinese herbal medicines is scientific, functional components in the Chinese herbal medicines are extracted through the technologies including ultrasonic secondary crushing, enzymolysis combined compound microorganism degradation and microwave assisted extraction method, the content of organic selenium in the product is increased, the nutritional healthy functions of the product are remarkably improved, and market prospects are wide.
Owner:QINGDAO JIARUI BIOLOGICAL TECH
Analogs of ghrelin substituted at the n-terminal
InactiveUS20090275511A1Reduce severityReduce the possibilityNervous disorderPeptide/protein ingredientsGhrelinAmino acid
The invention comprises peptidyl analogs of ghrelin having greater stability which are active at the GHS receptor according to formulae depicted below:(R2)-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25-A26-A27-A28-R1 wherein the definitions of A1 to A28, R1 and R2 are provided for in the specification, with the exception that the N-terminal amino acid must be selected from the group consisting of Inp, 1-Apc and 4-Apc, the pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising an effective amount of said compound together with therapeutic and non-therapeutic uses thereof.
Owner:IPSEN PHARMA SAS
Magnetic gastric band or the like, and related methods
ActiveUS20090062824A1Effective therapyReduce pressureElectrotherapyAnti-incontinence devicesBiomedical engineeringGastric band
Owner:TORAX MEDICAL
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
ActiveUS9386793B2Good for weight lossReduce the populationBiocideMetabolism disorderHigh fatAntibiotic Y
The present invention relates to characterizing changes in mammalian intestinal microbiota associated with associated with high-fat and low-fat diets and with diets containing hydroxypropylmethylcellulose (HPMC) and related methods for diagnosing, preventing and treating obesity and related conditions such as metabolic syndrome and diabetes mellitus. Therapeutic methods of the invention involve the use of probiotics, and / or prebiotics, and / or narrow spectrum antibiotics / anti-bacterial agents that are capable of restoring healthy mammalian bacterial intestinal microbiota.
Owner:NEW YORK UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com